You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Patent: 6,524,852

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,524,852
Title: Removing or increasing permeability of embryonic capsule to prepare equine embryos for cryopreservation
Abstract:A method for preparing an equine embryo for cryopreservation is provided. The method includes collecting an equine embryo with its embryonic capsule. Then after collection the embryo is treated to eliminate or increase the permeability of the capsule in which to enhance subsequent action of cryoprotectant(s). After the treatment the embryo is contacted with cryoprotectant(s) and then placed in a straw with the cryoprotectant(s). Furthermore, the capsule can be treated with enzymes such as collagenase and/or trypsin. Also the embryonic capsule may be removed by mechanical means before subjecting it to the action of cryoprotectant(s). The embryo may also be subjected to an enzymatic treatment to weaken the capsule.
Inventor(s): Legrand; Emmanuel (61200 Sevigny, FR)
Assignee: Legrand; Emmanuel (Sevigny, FR) Legrand; Rene (Sevigny, FR) Legrand; Odile (Sevigny, FR) Legrand; Richard (Sevigny, FR) Legrand; Jean-Pierre (Sevigny, FR) Buisson; Corinne Legrand (Bailleul, FR)
Application Number:09/445,740
Patent Claims:see list of patent claims

Details for Patent 6,524,852

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Legrand; Emmanuel (Sevigny, FR) Legrand; Rene (Sevigny, FR) Legrand; Odile (Sevigny, FR) Legrand; Richard (Sevigny, FR) Legrand; Jean-Pierre (Sevigny, FR) Buisson; Corinne Legrand (Bailleul, FR) 2017-06-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.